Drug Patent Expirations in September 2011

Drug Patent Expirations in September 2011

Drug Patent Expirations in September 2011

*Drugs may be covered by multiple patents

Tradename Applicant Generic Name Patent Number Patent Expiration
SEREVENT Glaxo Grp Ltd salmeterol xinafoate 7,225,808*PED Sep 1, 2011
ADVAIR DISKUS 500/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate 5,590,645*PED Sep 1, 2011
ADVAIR DISKUS 250/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate 6,792,945*PED Sep 1, 2011
ADVAIR DISKUS 250/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate 6,536,427*PED Sep 1, 2011
ADVAIR DISKUS 250/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate 6,378,519*PED Sep 1, 2011
ADVAIR DISKUS 250/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate 6,032,666*PED Sep 1, 2011
ADVAIR DISKUS 250/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate 5,860,419*PED Sep 1, 2011
ADVAIR DISKUS 250/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate 5,590,645*PED Sep 1, 2011
ADVAIR DISKUS 250/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate 7,389,775*PED Sep 1, 2011
ADVAIR DISKUS 250/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate 7,225,808*PED Sep 1, 2011
ADVAIR DISKUS 100/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate 7,225,808*PED Sep 1, 2011
ADVAIR DISKUS 100/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate 6,792,945*PED Sep 1, 2011
ADVAIR DISKUS 100/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate 6,536,427*PED Sep 1, 2011
ADVAIR DISKUS 500/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate 5,860,419*PED Sep 1, 2011
ADVAIR DISKUS 500/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate 6,032,666*PED Sep 1, 2011
SEREVENT Glaxo Grp Ltd salmeterol xinafoate 6,536,427*PED Sep 1, 2011
SEREVENT Glaxo Grp Ltd salmeterol xinafoate 5,860,419*PED Sep 1, 2011
SEREVENT Glaxo Grp Ltd salmeterol xinafoate 6,032,666*PED Sep 1, 2011
SEREVENT Glaxo Grp Ltd salmeterol xinafoate 6,378,519*PED Sep 1, 2011
SEREVENT Glaxo Grp Ltd salmeterol xinafoate 7,389,775*PED Sep 1, 2011
SEREVENT Glaxo Grp Ltd salmeterol xinafoate 6,792,945*PED Sep 1, 2011
SEREVENT Glaxo Grp Ltd salmeterol xinafoate 5,590,645*PED Sep 1, 2011
ADVAIR DISKUS 500/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate 7,389,775*PED Sep 1, 2011
ADVAIR DISKUS 500/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate 7,225,808*PED Sep 1, 2011
ADVAIR DISKUS 500/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate 6,792,945*PED Sep 1, 2011
ADVAIR DISKUS 500/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate 6,536,427*PED Sep 1, 2011
ADVAIR DISKUS 500/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate 6,378,519*PED Sep 1, 2011
ADVAIR DISKUS 100/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate 6,378,519*PED Sep 1, 2011
ADVAIR DISKUS 100/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate 6,032,666*PED Sep 1, 2011
ADVAIR DISKUS 100/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate 5,860,419*PED Sep 1, 2011
FLOVENT DISKUS 250 Glaxosmithkline fluticasone propionate 7,225,808*PED Sep 1, 2011
FLOVENT DISKUS 250 Glaxosmithkline fluticasone propionate 6,792,945*PED Sep 1, 2011
FLOVENT DISKUS 250 Glaxosmithkline fluticasone propionate 6,536,427*PED Sep 1, 2011
FLOVENT DISKUS 100 Glaxosmithkline fluticasone propionate 6,378,519*PED Sep 1, 2011
FLOVENT DISKUS 100 Glaxosmithkline fluticasone propionate 6,792,945*PED Sep 1, 2011
FLOVENT DISKUS 100 Glaxosmithkline fluticasone propionate 7,389,775*PED Sep 1, 2011
FLOVENT DISKUS 100 Glaxosmithkline fluticasone propionate 7,225,808*PED Sep 1, 2011
FLOVENT DISKUS 100 Glaxosmithkline fluticasone propionate 6,032,666*PED Sep 1, 2011
FLOVENT DISKUS 100 Glaxosmithkline fluticasone propionate 5,860,419*PED Sep 1, 2011
FLOVENT DISKUS 100 Glaxosmithkline fluticasone propionate 6,536,427*PED Sep 1, 2011
FLOVENT DISKUS 100 Glaxosmithkline fluticasone propionate 5,590,645*PED Sep 1, 2011
FLOVENT DISKUS 250 Glaxosmithkline fluticasone propionate 5,590,645*PED Sep 1, 2011
FLOVENT DISKUS 250 Glaxosmithkline fluticasone propionate 6,378,519*PED Sep 1, 2011
FLOVENT DISKUS 250 Glaxosmithkline fluticasone propionate 7,389,775*PED Sep 1, 2011
FLOVENT DISKUS 250 Glaxosmithkline fluticasone propionate 6,032,666*PED Sep 1, 2011
FLOVENT DISKUS 50 Glaxosmithkline fluticasone propionate 7,389,775*PED Sep 1, 2011
FLOVENT DISKUS 50 Glaxosmithkline fluticasone propionate 6,378,519*PED Sep 1, 2011
FLOVENT DISKUS 50 Glaxosmithkline fluticasone propionate 6,032,666*PED Sep 1, 2011
FLOVENT DISKUS 50 Glaxosmithkline fluticasone propionate 5,860,419*PED Sep 1, 2011
FLOVENT DISKUS 50 Glaxosmithkline fluticasone propionate 5,590,645*PED Sep 1, 2011
ADVAIR DISKUS 100/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate 7,389,775*PED Sep 1, 2011
ADVAIR DISKUS 100/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate 5,590,645*PED Sep 1, 2011
FLOVENT DISKUS 50 Glaxosmithkline fluticasone propionate 7,225,808*PED Sep 1, 2011
FLOVENT DISKUS 50 Glaxosmithkline fluticasone propionate 6,792,945*PED Sep 1, 2011
FLOVENT DISKUS 50 Glaxosmithkline fluticasone propionate 6,536,427*PED Sep 1, 2011
FLOVENT DISKUS 250 Glaxosmithkline fluticasone propionate 5,860,419*PED Sep 1, 2011
PRECEDEX Hospira dexmedetomidine hydrochloride 5,344,840 Sep 6, 2011
VISUDYNE Qlt verteporfin 5,095,030 Sep 9, 2011
VISIPAQUE 270 Ge Healthcare iodixanol 5,349,085 Sep 20, 2011
VISIPAQUE 320 Ge Healthcare iodixanol 5,349,085 Sep 20, 2011
SOMAVERT Pharmacia And Upjohn pegvisomant 5,681,809 Sep 27, 2011
SOMAVERT Pharmacia And Upjohn pegvisomant 5,350,836 Sep 27, 2011
SOMAVERT Pharmacia And Upjohn pegvisomant 5,958,879 Sep 27, 2011
SOMAVERT Pharmacia And Upjohn pegvisomant 6,583,115 Sep 27, 2011
ALIMTA Lilly pemetrexed disodium 5,217,974*PED Sep 29, 2011
GABITRIL Cephalon tiagabine hydrochloride 5,010,090 Sep 30, 2011

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.

Courtesy of DrugPatentWatch.com

NO COMMENTS

Leave a Reply